Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Gin Hwa BiotechROCO:7806 22 Interest Coverage is 125.50 as of Dec. 2025, which is 254% above its 10-year median of 35.48. GuruFocus rates ROCO:7806 with a GF Score™ of 22/100. The stock has 2 warning signs investors should review. Among 376 Biotechnology companies, Gin Hwa Biotech ranks worse than 59.84% on this metric.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's
Operating Income
by its Interest Expense. Gin Hwa Biotech's
Operating Income
for the
six
months ended in Dec. 2025 was NT$29.4 Mil. Gin Hwa Biotech's Interest Expense for the
six
months ended in Dec. 2025 was NT$-0.2 Mil.
Gin Hwa Biotech's interest coverage for the quarter that ended in Dec. 2025 was 125.50.
The higher the ratio, the stronger the company's financial strength is.
The historical rank and industry rank for Gin Hwa Biotech's Interest Coverage or its related term are showing as below:
ROCO:7806'
s Interest Coverage Range Over the Past 10 Years
Min: 17.32 Med: 35.48 Max: 48.03
Current: 40.53
ROCO:7806's Interest Coverage is ranked worse than 59.84% of 376
companies
in the Biotechnology industry
Industry Median: 104.025
vs ROCO:7806: 40.53
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
Gin Hwa Biotech Interest Coverage Related Terms
Gin Hwa Biotech Interest Coverage Historical Data
* Premium members only.
The historical data trend for Gin Hwa Biotech's Interest Coverage can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
ROCO:7806 vs VRTX, REGN, ALNY: Interest Coverage Comparison
For the Biotechnology subindustry, Gin Hwa Biotech's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Gin Hwa Biotech Interest Coverage vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Gin Hwa Biotech's Interest Coverage distribution charts can be found below:
* The bar in red indicates where Gin Hwa Biotech's Interest Coverage falls into.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Gin Hwa Biotech (ROCO:7806) has a Interest Coverage of 125.50 as of Dec. 2025. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Gin Hwa Biotech and its competitors. This is 254% above median its historical median of 35.48. Over the past decade, Gin Hwa Biotech's Interest Coverage has ranged from 17.32 to 48.03. According to the industry distribution chart, Gin Hwa Biotech ranks #225 out of 376 companies in the Biotechnology industry, placing it in the top 59.8%.
Is Gin Hwa Biotech's Interest Coverage too high?
Gin Hwa Biotech's current Interest Coverage of 125.50 is 254% above median its 10-year median of 35.48. Over the past 10 years, this metric has ranged from a low of 17.32 to a high of 48.03. The Biotechnology industry median Interest Coverage is 104.03. Gin Hwa Biotech's value of 125.50 is 20.6% above this industry median. Based on the distribution chart, Gin Hwa Biotech ranks #225 out of 376 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Gin Hwa Biotech has a GF Score™ of 22/100, reflecting its overall financial health beyond just this single metric.
How does Gin Hwa Biotech's Interest Coverage compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Gin Hwa Biotech ranks #225 out of 376 companies for Interest Coverage. This places Gin Hwa Biotech in the lower half of its industry. The industry median Interest Coverage is 104.03. Gin Hwa Biotech's value of 125.50 is 20.6% above this benchmark. Historically, Gin Hwa Biotech's own Interest Coverage has ranged from 17.32 to 48.03 over the past decade. While the company's 10-year median is 35.48 vs. the industry median of 104.03, Gin Hwa Biotech has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Biotechnology company?
The median Interest Coverage among Biotechnology companies is 104.03, based on 376 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Gin Hwa Biotech's current Interest Coverage of 125.50 is 20.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Gin Hwa Biotech and its competitors. For the Biotechnology industry, the median Interest Coverage is 104.03 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Gin Hwa Biotech's current Interest Coverage is 125.50, which is 254% above median its own 10-year median of 35.48. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Gin Hwa Biotech stock overvalued right now?
Gin Hwa Biotech (ROCO:7806) has a current Interest Coverage of 125.50. The current Interest Coverage is 125.50, which is 254% above median its 10-year median of 35.48 and 20.6% above the Biotechnology industry median of 104.03. Gin Hwa Biotech's overall GF Score™ is 22/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For Gin Hwa Biotech (ROCO:7806), the current Interest Coverage is 125.50 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Gin Hwa Biotech Inc is engaged in developing completely original products to achieve every vision. Its Services and technology are Product Development, OEM Service, Core Technology, R & D Center, Professional Production, and Others.
22GF Score
Get the complete analysis for ROCO:7806
Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:7806 has been successfully added to your 
